Records containing: T2DM
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Subjects With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2026-04-06A Single-Center, Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2026-03-27A Randomized, Double-blind, Placebo-controlled Mechanistic Study to Evaluate the Effect of HTD1801 in Delaying the Progression of Renal Impairment in Patients With Type 2 Diabetes and Chronic Kidney Disease.
-
CLINICAL_TRIALS study record update · 2026-03-24The Effect of Alogliptin Combined With Pioglitazone and Metformin Hydrochloride Tablets on Glucose and Lipid Metabolism and Islet Function in Patients With Type 2 Diabetes Mellitus Complicated With Metabolic Dysfunction-associated Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-03-23Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-19Voice Biomarkers for Type 2 Diabetes Detection: A Two-Stage Validation Study
-
CLINICAL_TRIALS study record update · 2025-12-26Effects of Intraduodenal Calcium on Plasma Glucose, Glucoregulatory Hormones and Gastric Emptying in Response to a Mixed-nutrient Drink in Humans With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-11-19A Multicentre, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of Pioglitazone Co-administration in Patients With Type II Diabetes With Insufficient Glycemic Control With Metformin and Empagliflozin Combination Therapy
-
CLINICAL_TRIALS study record update · 2025-11-13Feasibility of Use of Fitbit, Brief DSMES, and Targeted Text Messaging in Sedentary Adults With Type 2 Diabetes in Primary Care Settings
-
CLINICAL_TRIALS study record update · 2025-11-12Pilot of a CGM-Augmented Food Is Medicine Intervention
-
CLINICAL_TRIALS study record update · 2025-09-19A Prospective Observational Study on Metabolic Surgery for the Treatment of Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2025-09-17The Effect of Semaglutide on Osteoporotic Fractures in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-09-10A Phase 3, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of XW003 in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone
-
CLINICAL_TRIALS study record update · 2025-08-24A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of RAY1225 Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
-
CLINICAL_TRIALS study record update · 2025-08-24A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-08-11A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Trial and Open-Label Extension Study to Evaluate the Efficacy and Safety of Add-On Therapy With Empagliflozin for Patients With Inadequately Controlled Type 2 DiabetesMellitus in the Combination Treatment With Metformin and Alogliptin
-
CLINICAL_TRIALS study record update · 2025-06-13Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes: A Multicenter, Randomized, Open-Label, Active-Controlled, Non-inferiority Trial
-
CLINICAL_TRIALS study record update · 2025-05-08A Phase 3, Multi-center, Open-label, Randomized Study to Evaluate the Efficacy and Safety of XW003 Versus Dulaglutide in Patients With T2DM Inadequately Controlled by Metformin
-
CLINICAL_TRIALS study record update · 2025-05-02Comparing the Efficacy and Safety Between Short-term Continuous Subcutaneous Beinaglutide Injection and Continuous Subcutaneous Insulin Infusion (CSII) for Treatment of Patients With Newly Diagnosed Type 2 Diabetes: a Multicenter, Randomized Open Trial Study With Parallel Controls
-
CLINICAL_TRIALS study record update · 2025-04-20The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
-
CLINICAL_TRIALS study record update · 2025-01-28Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2024-12-16A Multicenter, Pivotal, Randomized Controlled Trial Comparing the Safety and Efficacy of an Automated Insulin Delivery System With the Standard of Care in Adults With Type 2 Diabetes (EMBRACE-T2D)
-
CLINICAL_TRIALS study record update · 2024-11-13Comprehensive Clinical Evaluation Study of GLP-1RA
-
CLINICAL_TRIALS study record update · 2023-10-11A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2023-06-15A Phase I Study to Evaluate the Drug-Drug Interaction of Chiglitazar With Empagliflozin，Atorvastatin and Valsartan in Healthy Subjects.